Companies / Creative Biolabs / "Anti-ERBB3_EGFR (XHM342_Cetuximab) h(CD28-CD3_) TanCAR, pCDCAR1"
Creative Biolabs

"Anti-ERBB3_EGFR (XHM342_Cetuximab) h(CD28-CD3_) TanCAR, pCDCAR1" | Creative Biolabs

The vector of anti-ERBB3_EGFR tandem chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human ERBB3 and EGFR. The T cells are genetically modified through transduction with a lentiviral vector expressing bivalent scFv of anti-ERBB3_EGFR antibody and linked to CD28 and CD3_ signaling domains. And the vector product was designed for the treatment of Head and Neck Squamous Cell Carcinoma.

Supporting Documents


Data Sheet

Datasheet

Reviews


No reviews yet

ABOUT THE COMPANY

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.